Nilvadipine

Jump to navigation Jump to search
Nilvadipine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H19N3O6
Molar mass385.370 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Nilvadipine

Articles

Most recent articles on Nilvadipine

Most cited articles on Nilvadipine

Review articles on Nilvadipine

Articles on Nilvadipine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nilvadipine

Images of Nilvadipine

Photos of Nilvadipine

Podcasts & MP3s on Nilvadipine

Videos on Nilvadipine

Evidence Based Medicine

Cochrane Collaboration on Nilvadipine

Bandolier on Nilvadipine

TRIP on Nilvadipine

Clinical Trials

Ongoing Trials on Nilvadipine at Clinical Trials.gov

Trial results on Nilvadipine

Clinical Trials on Nilvadipine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nilvadipine

NICE Guidance on Nilvadipine

NHS PRODIGY Guidance

FDA on Nilvadipine

CDC on Nilvadipine

Books

Books on Nilvadipine

News

Nilvadipine in the news

Be alerted to news on Nilvadipine

News trends on Nilvadipine

Commentary

Blogs on Nilvadipine

Definitions

Definitions of Nilvadipine

Patient Resources / Community

Patient resources on Nilvadipine

Discussion groups on Nilvadipine

Patient Handouts on Nilvadipine

Directions to Hospitals Treating Nilvadipine

Risk calculators and risk factors for Nilvadipine

Healthcare Provider Resources

Symptoms of Nilvadipine

Causes & Risk Factors for Nilvadipine

Diagnostic studies for Nilvadipine

Treatment of Nilvadipine

Continuing Medical Education (CME)

CME Programs on Nilvadipine

International

Nilvadipine en Espanol

Nilvadipine en Francais

Business

Nilvadipine in the Marketplace

Patents on Nilvadipine

Experimental / Informatics

List of terms related to Nilvadipine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Nilvadipine is a calcium channel blocker (CCB) used for the treatment of hypertension and chronic major cerebral artery occlusion.

Pathohistochemical studies have revealed that the volume of the infarction in the middle cerebral artery occlusion model could be decreased by nilvadipine.

Nilvadipine was tested in clinical trial as a possible treatment for Alzheimer's Disease in Ireland by the Roskamp Institute, Florida, USA and Trinity College, Ireland.[1]

Following this study, an international research consortium led by Trinity College Dublin (Ireland) in May 2011 announced the selection for funding of a large-scale European clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota. More than 500 Alzheimer’s patients will participate in the multicenter Phase III clinical trial designed to study the effectiveness of Nilvadipine.[2]

References

Template:Calcium channel blockers